Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. Hwang ES, Hyslop T, Lynch T, Ryser MD, et al. JAMA 2025;333:972-980.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hwang ES, Hyslop T, Lynch T, Ryser MD, et al. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA 2025;333:972-980.
PMID: 39665585